Nicorette Mini Lozenge Efficacy

Nicorette mini Lozenges

Nicorette mini Lozenges have been shown to reduce withdrawal symptoms of irritability, frustration, and anger associated with quitting smoking.¹*

Nicorette mini Lozenge adjusted cravings score and time postdose

Proven efficacy of Nicorette mini Lozenges

Significant craving relief at 3, 5, 7, and 10 minutes post-dose^2†ǂ

Starts to relieve cravings in just 3 minutes.^2†

Read more about Nicotine Replacement Therapy (NRT)

NicoDerm CQ Patch

Find out how the NicoDerm CQ Patch can help your patients.

Find out more

Nicorette Gum

Find out how Nicorette Gum can help your patients.

Find out more

Nicorette Lozenge

Find out how Nicorette Lozenges can help your patients.

Find out more

Nicorette Coated Ice Mint Lozenges

Effective craving relief with a better sensory experience for patients.

Find out more

Benefits of Quitting

Find out more about the benefits of quitting smoking.

Find out more

Patient care resources

Download resources for your patients.

Find out more

Patient FSA / HSA Eligible Product

This product is eligible for Flexible Spending Account (FSA) and Health Savings Accounts (HSA)

Resulting from the CARES Act recently passed by congress, you can now use your FSA and HSA tax-preferred savings account to purchase certain OTC products such as Flonase, Nicorette, Nicoderm, Advil, Voltaren, and Denture Care Products. Your plan details may vary, so make sure to save your receipt and check with your benefits or health provider for eligibility. Please visit our page on Using My FSA/HSA.

*Based on bioequivalence between 4-mg Nicorette mini Lozenges and standard lozenges. Behavioral support program increases chances of success. Use as directed.
†Versus placebo. 4 mg only.
ǂCraving relief was statistically significantly different between Nicorette mini Lozenge and placebo at p<0.05. Read label and use the product as directed.

References

Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal. J Clin Psychopharmacol. 2008;28(6):667-674.
National Institutes of Health, US National Library of Medicine. Provoked Craving Assessment. https://clinicaltrials.gov/ct2/show/results/NCT01506908 Updated March 12, 2014. Accessed January 6, 2019.

This site is intended for US healthcare professionals only.

PM-US-NICO-20-00114